- Home
- CLDX vs DNN Comparison
CLDX vs DNN Comparison
Compare CLDX & DNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- DNN
- Stock Information
- Founded
- CLDX N/A
- DNN 1936
- Country
- CLDX United States
- DNN Canada
- Employees
- CLDX N/A
- DNN N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- DNN Other Metals and Minerals
- Sector
- CLDX Health Care
- DNN Basic Materials
- Exchange
- CLDX Nasdaq
- DNN Nasdaq
- Market Cap
- CLDX 1.3B
- DNN 1.3B
- IPO Year
- CLDX 2008
- DNN 1997
- Fundamental
- Price
- CLDX $21.35
- DNN $1.67
- Analyst Decision
- CLDX Buy
- DNN Strong Buy
- Analyst Count
- CLDX 9
- DNN 2
- Target Price
- CLDX $50.00
- DNN $3.00
- AVG Volume (30 Days)
- CLDX 1.0M
- DNN 112.5M
- Earning Date
- CLDX 08-07-2025
- DNN 05-12-2025
- Dividend Yield
- CLDX N/A
- DNN N/A
- EPS Growth
- CLDX N/A
- DNN N/A
- EPS
- CLDX N/A
- DNN N/A
- Revenue
- CLDX $7,559,000.00
- DNN $3,176,679.00
- Revenue This Year
- CLDX N/A
- DNN $288.69
- Revenue Next Year
- CLDX N/A
- DNN $22.40
- P/E Ratio
- CLDX N/A
- DNN N/A
- Revenue Growth
- CLDX 24.49
- DNN 24.45
- 52 Week Low
- CLDX $14.40
- DNN $1.08
- 52 Week High
- CLDX $47.00
- DNN $2.47
- Technical
- Relative Strength Index (RSI)
- CLDX 59.74
- DNN 58.92
- Support Level
- CLDX $19.25
- DNN $1.51
- Resistance Level
- CLDX $20.56
- DNN $1.72
- Average True Range (ATR)
- CLDX 1.13
- DNN 0.10
- MACD
- CLDX 0.04
- DNN 0.00
- Stochastic Oscillator
- CLDX 97.22
- DNN 71.79
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About DNN Denison Mines Corp (Canada)
Denison Mines Corp is a uranium exploration and development company focused on the Athabasca Basin region of northern Saskatchewan, Canada. The company holds a noteworthy 95% interest in its flagship Wheeler River Uranium Project, the undeveloped uranium project located in the infrastructure-rich eastern part of the Athabasca Basin. Additionally, it is involved in mine decommissioning and environmental services through its Closed Mines group, which manages the Elliot Lake reclamation projects and offers third-party post-closure mine care and maintenance services. The Company operates in two main segments: the Mining segment and the Corporate and Other segment. The majority of revenue is generated from the mining segment.